The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Open accessAbstract
The cyclopentenone prostaglandins PGA 2, PGA 1, and PGJ 2 are formed by dehydration within the cyclopentane ring of PGE 2, PGE 1, and PGD 2. PGJ 2 is metabolized further to yield Δ 12‐PGJ 2 and 15‐deoxy‐Δ 12,14‐PGJ 2 (15d‐PGJ 2). Various compounds within the cyclopentenone prostaglandin family possess potent anti‐inflammatory, anti‐neoplastic, and anti‐viral activity. Most actions of the cyclopentenone prostaglandins do not appear to be mediated by binding to G‐protein coupled prostanoid receptors. Rather, the bioactivity of these compounds results from their interaction with other cellular target proteins. 15‐deoxy‐Δ 12,14‐PGJ 2 is a high affinity ligand for the nuclear receptor PPARγ and modulates gene transcription by binding to this receptor. Other activities of the cyclopentenone prostaglandins are mediated by the reactive α,β‐unsaturated carbonyl group located in the cyclopentenone ring. The transcription factor NF‐κB and its activating kinase are key targets for the anti‐inflammatory activity of 15d‐PGJ 2, which inhibits NF‐κB‐mediated transcriptional activation by PPARγ‐dependent and independent molecular mechanisms. Other cyclopentenone prostaglandins, such as Δ 7‐PGA 1 and Δ 12‐PGJ 2, have strong anti‐tumor activity. These compounds induce cell cycle arrest or apoptosis of tumor cells depending on the cell type and treatment conditions. We review here recent progress in understanding the mechanisms of action of the cyclopentenone prostaglandins and their possible use as therapeutic agents. © 2001 John Wiley & Sons, Inc. Med Res Rev, 21, No. 3, 185–210, 2001
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Self-citationHayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083491 · Cited by 3,464
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Self-citationKamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Self-citationForman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
Self-citationRoles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Transcriptional regulation of adipogenesis
Rosen, E. D., Walkey, C. J., Puigserver, P., & Spiegelman, B. M. (2000) · Genes & Development · doi:10.1101/gad.14.11.1293 · Cited by 1,898
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Self-citationTripartite Management of Unfolded Proteins in the Endoplasmic Reticulum
Mori, K. (2000) · Cell · doi:10.1016/s0092-8674(00)80855-7 · Cited by 918
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
Heat shock factors and the control of the stress response
Santoro, M. G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00299-3 · Cited by 581
Madrid, L. V., Wang, C.-Y., Guttridge, D. C., Schottelius, A. J. G., Baldwin, A. S., & Mayo, M. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1626-1638.2000 · Cited by 540
Verdin, E., Paras, P., & Van Lint, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 510
Regulation and function of the JNK subgroup of MAP kinases
Minden, A., & Karin, M. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00018-8 · Cited by 484
Prostaglandin and thromboxane biosynthesis
Smith, W. L., Marnett, L. J., & DeWitt, D. L. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90054-p · Cited by 442
Fruchart, J.-C., Duriez, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00007 · Cited by 425
Bishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
The Logic of Chemical Synthesis: Multistep Synthesis of Complex Carbogenic Molecules (Nobel Lecture)
Corey, E. J. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199104553 · Cited by 411
Pereira, L. A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.663 · Cited by 389
Li, M., Pascual, G., & Glass, C. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4699-4707.2000 · Cited by 377
Self-citationAlbumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.
Fitzpatrick, F. A., & Wynalda, M. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44287-6 · Cited by 328
Petrova, T. V., Akama, K. T., & Van Eldik, L. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4668 · Cited by 314
The generation and actions of isoprostanes
Roberts II, L. J., & Morrow, J. D. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00162-2 · Cited by 305
Taub, M., Chuman, L., Saier, M. H., & Sato, G. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3338 · Cited by 304
Ricote, M., Huang, J. T., Welch, J. S., & Glass, C. K. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.733 · Cited by 304
Self-citationProstaglandin D synthase: Structure and function
(2000) · Vitamins & Hormones · doi:10.1016/s0083-6729(00)58022-4 · Cited by 299
Castrillo, A., Díaz-Guerra, M. J. M., Hortelano, S., Martín-Sanz, P., & Boscá, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1692-1698.2000 · Cited by 264
Cloning and Crystal Structure of Hematopoietic Prostaglandin D Synthase
Kanaoka, Y., Ago, H., Inagaki, E., Nanayama, T., Miyano, M., Kikuno, R., Fujii, Y., Eguchi, N., Toh, H., Urade, Y., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80374-8 · Cited by 258
Rossi, A., Elia, G., & Santoro, M. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.746 · Cited by 195
Drummond, I. A., Lee, A. S., Resendez, E., & Steinhardt, R. A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45277-5 · Cited by 191
Pazin, M. J., Sheridan, P. L., Cannon, K., Cao, Z., Keck, J. G., Kadonaga, J. T., & Jones, K. A. (1996) · Genes & Development · doi:10.1101/gad.10.1.37 · Cited by 186
Characterization of the Essential Gene glmM Encoding Phosphoglucosamine Mutase in Escherichia coli
Mengin-Lecreulx, D., & van Heijenoort, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.32 · Cited by 183
Antiproliferative prostaglandins activate heat shock transcription factor.
Amici, C., Sistonen, L., Santoro, M. G., & Morimoto, R. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6227 · Cited by 179
Histone acetyltransferases regulate HIV-1 enhancer activity in vitro
Sheridan, P. L., Mayall, T. P., Verdin, E., & Jones, K. A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3327 · Cited by 179
Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.
Kerppola, T. K., Luk, D., & Curran, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3782 · Cited by 168
Kumar, S., Rabson, A. B., & Gélinas, C. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.7.3094 · Cited by 165
Huttner, J. J., Gwebu, E. T., Panganamala, R. V., et al. (1977) · Science · doi:10.1126/science.877555 · Cited by 156
Formation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway
Chen, Y., Morrow, J. D., & Roberts, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10863 · Cited by 155
Kikawa, Y., Narumiya, S., Fukushima, M., Wakatsuka, H., & Hayaishi, O. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1317 · Cited by 153
Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved.
Fukushima, M. (1990) · PubMed · Cited by 146
Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine.
Hirata, Y., Hayashi, H., Ito, S., Kikawa, Y., Ishibashi, M., Sudo, M., Miyazaki, H., Fukushima, M., Narumiya, S., & Hayaishi, O. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37435-0 · Cited by 145
Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1
Evers, R., Cnubben, N. H. P., Wijnholds, J., van Deemter, L., van BLADEREN, P. J., & Borst, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01442-7 · Cited by 138
Tolédano, M. B., Ghosh, D., Trinh, F., & Leonard, W. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.852 · Cited by 126
Gorospe, M., Liu, Y., Xu, Q., Chrest, F. J., & Holbrook, N. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.762 · Cited by 110
Cyclopentenone Prostaglandins as Potential Inducers of Phase II Detoxification Enzymes
Kawamoto, Y., Nakamura, Y., Naito, Y., Torii, Y., Kumagai, T., Osawa, T., Ohigashi, H., Satoh, K., Imagawa, M., & Uchida, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11291 · Cited by 98
Bogaards, J. J. P., Venekamp, J. C., & van BLADEREN, P. J. (1997) · Chemical Research in Toxicology · doi:10.1021/tx9601770 · Cited by 97
Different responsiveness of prostaglandin D2‐sensitive systems to prostaglandin D2 and its analogues
Narumiya, S., & Toda, N. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb08870.x · Cited by 94
Function and Regulation of Prostaglandin Synthase 2
Herschman, H. R., Xie, W., & St, R. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_1 · Cited by 93
Atsmon, J., Sweetman, B. J., Baertschi, S. W., Harris, T. M., & Roberts, L. J. (1990) · Biochemistry · doi:10.1021/bi00467a023 · Cited by 88
Peroxisome proliferator-activated receptor-γ: a versatile metabolic regulator
Rocchi, S., & Auwerx, J. H. (1999) · Annals of Medicine · doi:10.3109/07853899908995901 · Cited by 80
Kharroubi, A. E., & Verdin, E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32107-5 · Cited by 78
Levuglandin E2 crosslinks proteins
Iyer, R. S., Ghosh, S. K., & Salomon, R. G. (1989) · Prostaglandins · doi:10.1016/0090-6980(89)90096-8 · Cited by 78
Wright, D. H., Metters, K. M., Abramovitz, M., & Ford‐Hutchinson, A. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701708 · Cited by 76
Choung, J., Taylor, L., Thomas, K. M., Zhou, X. C., Kagan, H. M., Yang, X., & POLGAR, P. R. (1998) · PubMed · Cited by 68
Holbrook, N. J., Carlson, S. G., Choi, A. M. K., & Fargnoli, J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1528-1534.1992 · Cited by 67
Ohno, K., Fujiwara, M., Fukushima, M., & Narumiya, S. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80062-6 · Cited by 67
Role of p21 in prostaglandin A2-mediated cellular arrest and death.
Gorospe, M., & Holbrook, N. J. (1996) · PubMed · Cited by 63
Otto, A. M., Nilsen‐Hamilton, M., Boss, B. D., Ulrich, M. O., & de Asúa, L. J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.16.4992 · Cited by 62
Characterization of the Lysyl Adducts Formed from Prostaglandin H2 via the Levuglandin Pathway
Boutaud, O. G., Brame, C. J., Salomon, R. G., Roberts, L. J., & Oates, J. A. (1999) · Biochemistry · doi:10.1021/bi990470+ · Cited by 60
Choung, J., Taylor, L., Thomas, K. M., Zhou, X. C., Kagan, H. M., Yang, X., & POLGAR, P. R. (1998) · Journal of Cellular Biochemistry · Cited by 58
Formation of DNA-protein cross-links in mammalian cells by levuglandin E2
Murthi, K. K., Friedman, L. R., Oleinick, N. L., & Salomon, R. G. (1993) · Biochemistry · doi:10.1021/bi00066a034 · Cited by 56
Bui, T., & Straus, D. S. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00214-5 · Cited by 55
Self-citationSalomon, R. G., Sha, W., Brame, C. J., Kaur, K., Subbanagounder, G., O'NEIL, J. A., Hoff, H. F., & Roberts, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20271 · Cited by 54
Prostaglandins in the treatment of cancer
Sasaki, H., & Fukushima, M. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199404000-00002 · Cited by 53
Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E1.
Aglietta, M., Piacibello, W., & Gavosto, F. (1980) · PubMed · Cited by 51
Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus
SANTORO, M. G., Favalli, C., Mastino, A., et al. (1988) · Archives of Virology · doi:10.1007/bf01311026 · Cited by 48
Induction of ferritin and heat shock proteins by prostaglandin A1 in human monocytes
Elia, G., Polla, B. S., Rossi, A., & Santoro, M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00610.x · Cited by 47
Koizumi, T., Odani, N., Okuyama, T., Ichikawa, A., & Negishi, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21779 · Cited by 47
Rossi, A., & SANTORO, M. G. (1995) · Biochemical Journal · doi:10.1042/bj3080455 · Cited by 42
Calcium mediates expression of stress‐response genes in prostaglandin A 2 ‐induced growth arrest
Choi, A. M. K., Tucker, R. W., Carlson, S. G., Wiegand, G. W., & Holbrooke, N. J. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.13.7926370 · Cited by 41
Ishikawa, T., Akimaru, K., Nakanishi, M., Tomokiyo, K., Furuta, K., Suzuki, M., & Noyori, R. (1998) · Biochemical Journal · doi:10.1042/bj3360569 · Cited by 38
Cell growth inhibition by prostaglandin A2 results in elevated expression of gadd153 mRNA
Choi, A. M. K., Fargnoli, J., Carlson, S. G., & Holbrook, N. J. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90464-j · Cited by 38
Intracellular glutathione level modulates the induction of apoptosis by Δ12-prostaglandin J2
Kim, H., Lee, J., & Kim, I. (1996) · Prostaglandins · doi:10.1016/0090-6980(96)00047-0 · Cited by 37
Induction of γ-glutamylcysteine synthetase by prostaglandin A2 in L-1210 cells
Ohno, K., & Hirata, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92356-5 · Cited by 33
Chen, Y., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00168-4 · Cited by 31
On the identification and biological properties of prostaglandin J2
Mahmud, I., Smith, D. L., Whyte, M. A., Nelson, J. T., Cho, D., Tokes, L., Alvarez, R., & Willis, A. L. (1984) · Prostaglandins Leukotrienes and Medicine · doi:10.1016/0262-1746(84)90066-0 · Cited by 30
Interactions of prostaglandin A2 with the glutathione-mediated biotransformation system
van Iersel, M. L. P. S., Cnubben, N. H. P., Smink, N., Koeman, J. H., & van BLADEREN, P. J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00048-9 · Cited by 29
Induction ofMRP/GS-X pump and cellular resistance to anticancer prostaglandins
Akimaru, K., Kuo, M. T., 古田, 享., Suzuki, M., Noyori, R., & Ishikawa, T. (1996) · Cytotechnology · doi:10.1007/bf00744216 · Cited by 22
Haberl, C., Hültner, L., Flügel, A., Falk, M., Geuenich, S., Wilmanns, W., & Denzlinger, C. (1998) · Mediators of Inflammation · doi:10.1080/09629359891216 · Cited by 19
Cited by
Spoel, S. H., Koornneef, A., Claessens, S. M. C., Korzelius, J. P., Van Pelt, J. A., Mueller, M. J., Buchala, A. J., Métraux, J.-P., Brown, R., Kazan, K., et al. (2003) · The Plant Cell · doi:10.1105/tpc.009159 · Cited by 1,227
ABC transporters in cancer: more than just drug efflux pumps
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2789 · Cited by 1,018
Anti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862
Inflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00788 · Cited by 588
Metadata
- Authors
- Straus, D. S., & Glass, C. K.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2001-04-06
- Volume
- 21
- Issue
- 3
- Pages
- 185-210
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2058218787
- Cited by
- 576
- References
- 90
- FWCI
- 22.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.